Diffusion Pharmaceuticals appoints General Counsel William Elder as principal financial officer

CervoMed Inc.

William Elder, previously General Counsel and Corporate Secretary, appointed principal financial officer effective June 14, 2023.
No changes to Elder's existing employment agreement, equity awards, or compensation in connection with the appointment.
No arrangements or understandings with any other person regarding Elder's selection; no family relationships with directors or officers.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William Elder

principal financial officer

CRVO · CervoMed Inc.

Effective: 2023-06-14
Filed: June 21, 2023, 7:59 PM ET

On June 14, 2023, following the previously reported departure of the former Chief Financial Officer of Diffusion Pharmaceuticals Inc. (“Diffusion” or the “Company”), the Company’s board of directors appointed William Elder, Diffusion’s General Counsel and Corporate Secretary, as the Company’s principal financial officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

William Elder was appointed as principal financial officer at CervoMed Inc..

Action: appointed
Role: principal financial officer

Exact text from the filing

On June 14, 2023, following the previously reported departure of the former Chief Financial Officer of Diffusion Pharmaceuticals Inc. (“Diffusion” or the “Company”), the Company’s board of directors appointed William Elder, Diffusion’s General Counsel and Corporate Secretary, as the Company’s principal financial officer.

View on SEC.gov

CervoMed Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-017990

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.